New study aims to decode Sepsis-Related heart and blood vessel failure

NCT ID NCT07442032

Not yet recruiting Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will look at 400 adults with sepsis and unstable blood pressure to understand how their heart and blood vessels are affected. Researchers will use ultrasound and blood tests to classify patients into different groups based on their heart and blood vessel function. The main goal is to see if these groups are linked to the risk of dying within one year. This research aims to improve understanding of sepsis and help develop more personalized treatments in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors better understand and classify heart and blood vessel problems in sepsis, leading to more personalized care.
What could go wrong: This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, so it cannot prove a new treatment works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder infectious disease with sepsis Sepsis toxic shock syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DYSFUNCTION MICROCIRCULATORY DYSFUNCTION PERIPHERAL VASCULAR RESPONSE SEPSIS SEPTIC SHOCK TROPONIN ELEVATION

More trials for these conditions

Other studies related to the condition(s) this trial covers.